Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

NASDAQ:LFVN - US53222K2050 - Common Stock

13.1 USD
0 (0%)
Last: 8/29/2025, 8:00:02 PM
13.1 USD
0 (0%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LFVN. LFVN was compared to 35 industry peers in the Personal Care Products industry. LFVN gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on LFVN. With these ratings, LFVN could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

LFVN had positive earnings in the past year.
LFVN had a positive operating cash flow in the past year.
LFVN had positive earnings in each of the past 5 years.
LFVN had a positive operating cash flow in each of the past 5 years.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 11.85%, LFVN belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
LFVN has a Return On Equity of 26.91%. This is amongst the best in the industry. LFVN outperforms 94.29% of its industry peers.
LFVN has a better Return On Invested Capital (18.87%) than 85.71% of its industry peers.
LFVN had an Average Return On Invested Capital over the past 3 years of 8.14%. This is below the industry average of 12.91%.
The last Return On Invested Capital (18.87%) for LFVN is above the 3 year average (8.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.85%
ROE 26.91%
ROIC 18.87%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150 200

1.3 Margins

The Profit Margin of LFVN (4.12%) is better than 65.71% of its industry peers.
In the last couple of years the Profit Margin of LFVN has declined.
LFVN has a Operating Margin (5.83%) which is in line with its industry peers.
LFVN's Operating Margin has declined in the last couple of years.
LFVN has a Gross Margin of 80.29%. This is amongst the best in the industry. LFVN outperforms 100.00% of its industry peers.
LFVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.83%
PM (TTM) 4.12%
GM 80.29%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LFVN is creating value.
The number of shares outstanding for LFVN has been reduced compared to 1 year ago.
Compared to 5 years ago, LFVN has less shares outstanding
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFVN has an Altman-Z score of 4.18. This indicates that LFVN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LFVN (4.18) is better than 65.71% of its industry peers.
LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.18
ROIC/WACC2.13
WACC8.87%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.66 indicates that LFVN should not have too much problems paying its short term obligations.
LFVN has a Current ratio (1.66) which is comparable to the rest of the industry.
LFVN has a Quick Ratio of 1.66. This is a bad value and indicates that LFVN is not financially healthy enough and could expect problems in meeting its short term obligations.
LFVN has a Quick ratio (0.98) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.98
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.23% over the past year.
The Earnings Per Share has been decreasing by -6.69% on average over the past years.
Looking at the last year, LFVN shows a quite strong growth in Revenue. The Revenue has grown by 8.22% in the last year.
The Revenue has been decreasing by -2.40% on average over the past years.
EPS 1Y (TTM)26.23%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%23.81%
Revenue 1Y (TTM)8.22%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%21.13%

3.2 Future

Based on estimates for the next years, LFVN will show a very strong growth in Earnings Per Share. The EPS will grow by 33.40% on average per year.
The Revenue is expected to grow by 11.96% on average over the next years. This is quite good.
EPS Next Y40.69%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue Next Year13.91%
Revenue Next 2Y11.73%
Revenue Next 3Y11.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

LFVN is valuated rather expensively with a Price/Earnings ratio of 17.01.
LFVN's Price/Earnings ratio is rather cheap when compared to the industry. LFVN is cheaper than 82.86% of the companies in the same industry.
When comparing the Price/Earnings ratio of LFVN to the average of the S&P500 Index (27.08), we can say LFVN is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.78 indicates a correct valuation of LFVN.
Based on the Price/Forward Earnings ratio, LFVN is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of LFVN to the average of the S&P500 Index (22.72), we can say LFVN is valued slightly cheaper.
Industry RankSector Rank
PE 17.01
Fwd PE 12.78
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFVN indicates a somewhat cheap valuation: LFVN is cheaper than 74.29% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LFVN is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.77
EV/EBITDA 8.81
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

LFVN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFVN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LFVN's earnings are expected to grow with 33.40% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y32.94%
EPS Next 3Y33.4%

3

5. Dividend

5.1 Amount

LFVN has a Yearly Dividend Yield of 1.37%. Purely for dividend investing, there may be better candidates out there.
LFVN's Dividend Yield is a higher than the industry average which is at 5.54.
With a Dividend Yield of 1.37, LFVN pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

LFVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

21.94% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP21.94%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (8/29/2025, 8:00:02 PM)

After market: 13.1 0 (0%)

13.1

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)09-04 2025-09-04/amc
Inst Owners62.31%
Inst Owner Change17.25%
Ins Owners15.55%
Ins Owner Change-1.04%
Market Cap164.93M
Analysts82.86
Price Target30.6 (133.59%)
Short Float %22.47%
Short Ratio17.15
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend0.55
Dividend Growth(5Y)N/A
DP21.94%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.045)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.92%
Min EPS beat(2)56.07%
Max EPS beat(2)61.77%
EPS beat(4)2
Avg EPS beat(4)20.31%
Min EPS beat(4)-34.64%
Max EPS beat(4)61.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-6.06%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-5.1%
Min Revenue beat(4)-7.05%
Max Revenue beat(4)-1.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.01
Fwd PE 12.78
P/S 0.74
P/FCF 13.77
P/OCF 12.28
P/B 4.85
P/tB 4.88
EV/EBITDA 8.81
EPS(TTM)0.77
EY5.88%
EPS(NY)1.03
Fwd EY7.83%
FCF(TTM)0.95
FCFY7.26%
OCF(TTM)1.07
OCFY8.14%
SpS17.66
BVpS2.7
TBVpS2.68
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.85%
ROE 26.91%
ROCE 29.03%
ROIC 18.87%
ROICexc 37.98%
ROICexgc 38.37%
OM 5.83%
PM (TTM) 4.12%
GM 80.29%
FCFM 5.39%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
ROICexc(3y)14.83%
ROICexc(5y)33.63%
ROICexgc(3y)15.14%
ROICexgc(5y)35.34%
ROCE(3y)12.51%
ROCE(5y)23.24%
ROICexcg growth 3Y-29.46%
ROICexcg growth 5Y-27.73%
ROICexc growth 3Y-29.25%
ROICexc growth 5Y-26.49%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
F-Score7
Asset Turnover2.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.14%
Cap/Sales 0.65%
Interest Coverage 762.41
Cash Conversion 83.01%
Profit Quality 130.87%
Current Ratio 1.66
Quick Ratio 0.98
Altman-Z 4.18
F-Score7
WACC8.87%
ROIC/WACC2.13
Cap/Depr(3y)65.13%
Cap/Depr(5y)79.97%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.23%
Profit Quality(3y)232.22%
Profit Quality(5y)185.98%
High Growth Momentum
Growth
EPS 1Y (TTM)26.23%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%23.81%
EPS Next Y40.69%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue 1Y (TTM)8.22%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%21.13%
Revenue Next Year13.91%
Revenue Next 2Y11.73%
Revenue Next 3Y11.96%
Revenue Next 5YN/A
EBIT growth 1Y222.17%
EBIT growth 3Y-37.33%
EBIT growth 5Y-15.06%
EBIT Next Year104.6%
EBIT Next 3Y42.08%
EBIT Next 5YN/A
FCF growth 1Y295.25%
FCF growth 3Y-7.39%
FCF growth 5Y-8.22%
OCF growth 1Y129.5%
OCF growth 3Y-9.16%
OCF growth 5Y-7.27%